• Bhubaneswar India
  • Contact+ 91-9938772605
  • Mon - Sat : 10:00AM - 6:00PM

Tag: RGCIRC

Experts Gather at RGCIRC’s Onco Critical Care Conference to Address Key Challenges in Onco Critical Care

New Delhi, August 12: Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) organized the second annual conference on Onco Critical Care which brought together leading experts, intensivists, nurses, and health professionals working in critical care areas from the national capital and neighbouring regions to explore the gaps in oncology care.

The conference featured expert-led sessions and panel discussions for healthcare professionals who are committed to advancing their knowledge and skills in field of critical care.

Highlighting the significance of the conference in pushing the boundaries of onco critical care, D. S. Negi, CEO, RGCIRC, said, “Our commitment is to advance onco critical care by not only improving our clinical practices but also by fostering a collaborative environment for ongoing education and research. We are dedicated to ensuring that cancer patients receive the intensive care they need, when they need it, to improve their chances of recovery and quality of life.”

The theme of the conference resonates with the broader goal of improving patient outcomes and addressing the financial and emotional toll on cancer patients and their families.

Dr. Parveen Kaur, Consultant & Head MICU, RGCIRC and Organizing Chairperson of the conference, who emphasized the importance of such platforms for sharing knowledge and driving advancements in onco critical care saying, “Many cancer patients find themselves in the ICU due to complications from their disease or its treatment. The purpose of this conference is to raise awareness that cancer diagnosis is not a dead end. Intensive care is not just a reactive measure but an integral part of cancer care. Patients with cancer, irrespective of their stage, deserve the best possible intensive care.”

The sessions and panel discussions focused on topics including the “AI Maturity Roadmap for Effective and Sustainable Application in Healthcare,” “CAR T Cell Therapy: Pearls and Pitfalls,” and “Approach to Infections in Stem Cell Transplant Recipients.” The sessions also focused on addressing the complexities of providing organ support to cancer patients and how to optimize care based on individual needs and circumstances.

The Onco Critical Care Conference played a crucial role in advancing medical knowledge, fostering collaboration, and ultimately improving patient outcomes.

RGCIRC Successfully Complete Clinical Trials on Telesurgery Using SSI Mantra Robot

New Delhi, July 31: Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) has reached a landmark achievement with the successful completion of a clinical trial on telesurgery using the SSI Mantra Surgical Robotic System. This pioneering trial involved six surgical procedures including first surgery done on a patient of urinary bladder carcinoma followed by nephrectomy, hysterectomy and cystectomy showcasing telesurgery as a safe and effective medical practice. The success of this trial paves the way for public access to telesurgery which was widely unavailable in India.

Dr. Sudhir Kumar Rawal with team

The trial was conducted by a team of expert surgeons led by Dr Sudhir Rawal, Medical Director & Chief of Genito-Uro Oncology at RGCIRC along with Dr Vandana Jain, Dr Amitabh Singh and Dr Ashish Khanna. The procedures were executed flawlessly, with no technical issues or surgical complications reinstating that telesurgery can meet the high standards of traditional operating rooms.

RGCIRC and SS Innovations have a longstanding partnership aimed at enhancing access to high-quality healthcare across India. This collaboration aligns with the mission of ‘decentralizing excellence’ and positioning India at the forefront of global surgical innovation. RGCIRC has played a crucial role in developing the SSI Mantra robotic system, providing essential clinical feedback to refine the technology. This success exemplifies the ‘Make in India’ initiative, establishing its practical applications in real-world settings.

Dr Sudhir Rawal emphasized RGCI’s dedication to integrating cutting-edge technologies for patient benefit. “RGCIRC has partnered with SSI in leveraging the advancements in medical technology to empower surgeons and transform surgical procedures ensuring an experience on par with traditional operating room procedures. The success of the trials will help in establishing medical procedure while democratizing access to advanced healthcare services.”

One of the most significant advantages of telesurgery is that super specialists do not have to be physically present at the surgery location. Any qualified surgeon can manage the surgery in the operating theatre (OT) while the super-specialists perform the surgery remotely. This not only saves on travel costs for medical professionals but also lowers hospitalization expenses for patients by improving access to high-quality care remotely. This approach will greatly enhance access to specialized medical care, particularly in tier 2 and tier 3 cities, making advanced surgical procedures more accessible and affordable.

This successful trial builds on RGCIRC’s pioneering efforts, which began with India’s first-ever telesurgery in cancer care. The initial telesurgery, performed in collaboration with SS Innovations, marked a significant step in breaking geographical barriers in healthcare delivery. The ongoing trials and advancements underscore RGCIRC’s and SSI’s commitment to setting new benchmarks in the medical field.

As the trial concludes with successful outcomes, the future of telesurgery looks promising. This technology is poised to revolutionize healthcare delivery, especially in tier 2 and tier 3 cities where access to specialized medical care is often limited. By making advanced surgical procedures more accessible and affordable, RGCIRC and SSI are paving the way for a new era of medical excellence.